A carregar...
Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate
Somatic gain-of-function mutations in isocitrate dehydrogenase (NADP(+)) 1, cytosolic (IDH1) or isocitrate dehydrogenase (NADP(+)) 2, mitochondrial (IDH2) are bona fide oncogenic drivers of acute myeloid leukemia and glioma because the neomorphic enzymes catalyze the synthesis of R-2-hydroxylutarate...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Taylor & Francis Group
2018-12-01
|
Colecção: | OncoImmunology |
Assuntos: | |
Acesso em linha: | http://dx.doi.org/10.1080/2162402X.2018.1528815 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|